Cite
HARVARD Citation
Panagopoulos, P. et al. (2021). Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection. Journal of chemotherapy. pp. 193-197. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Panagopoulos, P. et al. (2021). Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection. Journal of chemotherapy. pp. 193-197. [Online].